Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 188 entries
View as:

Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06791148 Org: User:
Start: 07/10/24 End: 12/10/27 Due: 12/10/28

Clinical Characteristics of Metabolic Associated Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT06325254 Org: User:
Start: 01/01/10 End: 08/31/24 Due: 08/31/25

Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06389760 Org: User:
Start: 10/18/23 End: 09/30/26 Due: 09/30/27

Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT04216693 Org: User:
Start: 06/01/20 End: 06/01/23 Due: 06/01/24

Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04535687 Org: User:
Start: 12/17/20 End: 06/12/23 Due: 06/12/24

Influence of Different Prostheses on Postoperative Clinical Function in Total Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT06617819 Org: User:
Start: 09/30/24 End: 12/31/27 Due: 12/31/28

Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC

Phase: N/A Priority: Normal
NCT ID: NCT03199807 Org: User:
Start: 07/20/17 End: 07/20/21 Due: 07/20/22

The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection

Phase: N/A Priority: Normal
NCT ID: NCT05380999 Org: User:
Start: 05/31/22 End: 03/31/26 Due: 03/31/27

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Phase: N/A Priority: Normal
NCT ID: NCT06968806 Org: User:
Start: 09/01/25 End: 09/01/28 Due: 09/01/29

Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT06561906 Org: User:
Start: 09/01/20 End: 12/31/27 Due: 12/31/28

Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06085703 Org: User:
Start: 09/01/23 End: 06/30/26 Due: 06/30/27

Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures

Phase: N/A Priority: Normal
NCT ID: NCT06762704 Org: User:
Start: 02/28/25 End: 12/31/27 Due: 12/31/28

The Study on the Effectiveness and Safety of Electroacupuncture at ST36 in Treating Primary Premature Ejaculation

Phase: N/A Priority: Normal
NCT ID: NCT06172855 Org: User:
Start: 01/01/24 End: 12/30/25 Due: 12/30/26

AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06080854 Org: User:
Start: 11/10/23 End: 06/06/26 Due: 06/06/27

Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06095934 Org: User:
Start: 03/01/22 End: 12/30/25 Due: 12/30/26

Skin Biopsy in the Diagnosis of Small Fiber Neuropathy in Chinese Patients With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04071535 Org: User:
Start: 12/01/15 End: 07/01/21 Due: 07/01/22

Study on Prenatal Diagnosis and Closed-loop Management System of Congenital Talipes Equinovarus

Phase: N/A Priority: Normal
NCT ID: NCT05638490 Org: User:
Start: 08/03/22 End: 12/31/25 Due: 12/31/26

Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors

Phase: N/A Priority: Normal
NCT ID: NCT05768464 Org: User:
Start: 02/01/23 End: 12/30/27 Due: 12/30/28

Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC)

Phase: N/A Priority: Normal
NCT ID: NCT06551233 Org: User:
Start: 04/22/24 End: 12/31/25 Due: 12/31/26

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06391008 Org: User:
Start: 04/30/24 End: 06/30/25 Due: 06/30/26

Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05248282 Org: User:
Start: 09/01/21 End: 12/31/22 Due: 12/31/23

The Diagnostic Value of Shear Wave Elastography and Viscosity Imaging Techniques in Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06773793 Org: User:
Start: 04/07/24 End: 03/31/29 Due: 03/31/30

Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05543967 Org: User:
Start: 10/18/22 End: 08/31/25 Due: 08/31/26

Relationship and Central Mechanism Between Diabetes and Cognitive Impairment Based on Simultaneous EEG-fMRI Approach and Peripheral Neuropathology Biomarkers Assay

Phase: N/A Priority: Normal
NCT ID: NCT05545657 Org: User:
Start: 10/18/22 End: 08/31/25 Due: 08/31/26

Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT04322045 Org: User:
Start: 04/30/20 End: 12/31/22 Due: 12/31/23